EUVIMEDEUVIMED entdecken
Open Access

TIGIT stimulation suppresses autoimmune uveitis by inhibiting Th17 cell infiltration

Kayleigh Peters, Trisha McDonald, Fauziyya Muhammad, Adrien Brady, John Dostal, Darren J Lee iD

Journal of Leukocyte Biology · 2024

DOI: 10.1093/jleuko/qiae116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Kayleigh Peters und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, 608 Stanton L Young Blvd, Oklahoma City, OK 7310…. Hauptthemen laut MEDLINE: Uveitis, Th17 Cells, Receptors, Immunologic, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIH HHS, Research to Prevent Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell immunoglobulin and ITIM domain (TIGIT) is an immune checkpoint molecule that suppresses T cell activation and promotes an immunosuppressive environment to suppress autoimmune diseases. However, the impact of a TIGIT agonist as a treatment for ocular autoimmune disease has not been investigated. We examined TIGIT expression on T helper 17 (Th17) and regulatory T cells (Tregs), the role of TIGIT on experimental autoimmune uveitis and Th17 cells, and the impact of Treg generation following TIGIT stimulation. TIGIT stimulation at the onset of clinical symptoms reduced the severity of uveitis and suppressed infiltration of Th17 cells into the eye. Further, Tregs from mice treated with the TIGIT agonist were capable of suppressing experimental autoimmune uveitis in recipient mice. This report demonstrates that stimulation of TIGIT at onset of disease suppresses symptoms and allows for induction of regulatory immunity that provides resistance to uveitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UveitisTh17 CellsReceptors, ImmunologicT-Lymphocytes, RegulatoryAutoimmune DiseasesAnimalsMiceMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

TIGIT+ Tregsautoimmune uveitisocular immune privilegeth17 cells

Substanzen

Receptors, ImmunologicT cell Ig and ITIM domain protein, mouse

Autor:innen und Institutionen

  • Department of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, 608 Stanton L Young Blvd, Oklahoma City, OK 73104, United States.
  • Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., BMSB 1053, Oklahoma City, OK 73104, United States.
  • Department of Ophthalmology and Visual Sciences, University of Massachusetts Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, United States.

ORCID-Profile: Darren J Lee

Förderung

  • NEI NIH HHS
  • NIH HHS
  • Research to Prevent Blindness
  • National Institutes of Health
  • National Eye Institute

Zitieren

APA

Peters, K., McDonald, T., Muhammad, F., Brady, A., Dostal, J., & Lee, D. J. (2024). TIGIT stimulation suppresses autoimmune uveitis by inhibiting Th17 cell infiltration. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae116

Vancouver

Peters K, McDonald T, Muhammad F, Brady A, Dostal J, Lee DJ. TIGIT stimulation suppresses autoimmune uveitis by inhibiting Th17 cell infiltration. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae116

BibTeX
@article{Peters2024,
  author = {Peters, Kayleigh and McDonald, Trisha and Muhammad, Fauziyya and Brady, Adrien and Dostal, John and Lee, Darren J},
  title = {TIGIT stimulation suppresses autoimmune uveitis by inhibiting Th17 cell infiltration},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  doi = {10.1093/jleuko/qiae116}
}
Kostenlos starten →